Navigation Links
Pre-emptive pain regimen decreased opioid usage in patients undergoing robotic prostatectomy
Date:6/24/2010

(PHILADELPHIA) Reporting in the journal Urology, researchers at Thomas Jefferson University have found that a pre-emptive multimodal pain regimen that included pregabalin (Lyrica) decreased the use of opioid analgesics in patients undergoing robotic-assisted laparoscopic radical prostatectomy.

Opioid usage, which involves narcotic pain medications, was significantly less in patients who received the multimodal regimen compared to patients who received a standard postoperative analgesic regimen. The mean opioid dose, which was measured in "total morphine equivalent dose," was 75.3 mg for patients who received the standard regimen, versus 49.1 mg for patients who received the multimodal regimen.

"This is the first demonstration of the effectiveness of a pre-emptive pain management protocol using pregabalin in urologic surgery," said Edouard J. Trabulsi, M.D., associate professor of Urology at Jefferson Medical College of Thomas Jefferson University. "We think this study paves the way for new pain management protocols. Though a larger prospective study is necessary to accurately characterize the benefit of reducing opioids, it could have significant implications not only for robotic prostatectomy, but also other laparoscopic procedures and more painful surgeries."

Dr. Trabulsi and colleagues from the Urology and Anesthesiology departments at Jefferson conducted a retrospective study of 60 patients, all undergoing robotic prostatectomy. Thirty of the patients received the multimodal pre-operative treatment and 30 previous patients received only the standard postoperative analgesic regimen.

The pre-operative treatment included pregabalin, acetaminophen and celecoxib given orally, two hours before the procedure, and continued postoperatively in combination with intravenous ketorolac. The standard postoperative analgesic regimen included intravenous ketorolac, without pregabalin or celecoxib. All patients received oxycodone
'/>"/>

Contact: Emily Shafer
emily.shafer@jefferson.edu
215-955-6300
Thomas Jefferson University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. New treatment regimen shown effective against advanced ovarian cancer
2. Combination treatment regimen not effective against advanced melanoma
3. Longer Drug Regimen Still Best Against Breast Cancer
4. Antibiotic regimen effective for reactive arthritis
5. For a Healthier, Cleaner Fitness Regimen - Venture Products Shock Athletic(TM) Mats and Interlocking Flooring
6. Children With Cerebral Palsy Benefitting From New Physical Therapy Regimen
7. Mail-Order May Help People Stick to Med Regimens
8. Heel Pain Usually Relieved With Stretching Regimen
9. Blood stem-cell transplant regimen reverses sickle cell disease in adults
10. Decreased food intake during hospital stays is an independent risk factor for hospital mortality
11. CT and MRI scans associated with shorter hospital stays and decreased costs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... Summer is here, and with it comes ... summer, and they can be a pain for dogs. Animal ... all their customers get rid of ticks and prevent them ... in the summer, which is why they are so active ... and woodland areas and carry a number of diseases, including ...
(Date:8/1/2014)... Chicago, Illinois (PRWEB) August 01, 2014 ... filed across the country, Ronald E. Johnson, Jr. has ... injured by AndroGel and other testosterone medications. Since the ... & Johnson, P.S.C. have worked diligently to investigate and ... strokes, pulmonary embolisms, and blood clots as a result ...
(Date:8/1/2014)... Writing down fears, emotions and the benefits of a ... cancer survivors, according to a study conducted by a ... "The key to developing an expressive writing intervention is ... journal recording facts and events. Writing a journal can ... evidence to determine whether it,s effective or not," said ...
(Date:8/1/2014)... 2014 Growing prevalence of chronic ... reforms are boosting healthcare market growth, although a ... and increasing generic consumption is a major challenge. ... in 2013, having grown at a Compound Annual ... implementation of the Health Transformation Program (Saglikta Donus, ...
(Date:8/1/2014)... August 01, 2014 Hot off the presses ... spa category of the World’s Best Awards by Travel ... month-long celebration of National Relaxation Day (technically August 15). ... of MAJOR experts to help guests celebrate relaxation throughout the ... is for health and wellness to carve out time to ...
Breaking Medicine News(10 mins):Health News:Tis the Season for Tick Prevention 2Health News:Ron Johnson Named Co-Lead Counsel in Lawsuits for Men Injured by AndroGel and Testosterone 2Health News:Expressive writing may help breast cancer survivors 2Health News:Expressive writing may help breast cancer survivors 3Health News:Turkey Pharmaceutical and Medical Device Market Worth $21.5B & $3.3B by 2020 Respectively, Says a Report Available at MarketOptimizer.org 2Health News:Turkey Pharmaceutical and Medical Device Market Worth $21.5B & $3.3B by 2020 Respectively, Says a Report Available at MarketOptimizer.org 3Health News:Turkey Pharmaceutical and Medical Device Market Worth $21.5B & $3.3B by 2020 Respectively, Says a Report Available at MarketOptimizer.org 4Health News:The Lodge at Woodloch Kicks Off National Relaxation Day with a Month Long Celebration 2Health News:The Lodge at Woodloch Kicks Off National Relaxation Day with a Month Long Celebration 3Health News:The Lodge at Woodloch Kicks Off National Relaxation Day with a Month Long Celebration 4
... intellectual disability (ID, formerly mental retardation), have led to ... review of more than 100 studies on the topic ... . Aileen Healy and colleagues explain that people ... with medical care focusing on relieving some of the ...
... 2011) - For the first time, researchers at McMaster ... gut influence brain chemistry and behaviour. The findings ... including irritable bowel syndrome, are frequently associated with anxiety ... some psychiatric disorders, such as late onset autism, may ...
... May, 2011 - New analysis published by the UK journal ... abortion in Poland has led to the development of a ... of care or accountability. Since abortion became illegal in the ... has fallen by 99%. The private trade in abortions is, ...
... Kan. -- Mosquitoes are becoming more resistant to current ... Michel, as it means malaria and other mosquito-borne diseases ... Institutes of Health may change all that. Michel, ... $1.5 million grant for the four-year study, "The function(s) ...
... MONDAY, May 16 (HealthDay News) -- When general doctors refer ... it,s more often another lesion that turns out to be ... might benefit from increased education on skin cancer detection, the ... the very high number of incidentally detected skin cancers," said ...
... Ill. A simple blood test may help prevent a ... MRI exams, according to a study published in the July ... five years, use of gadolinium-based contrast agents (GBCA) has been ... rare disorder mainly affecting patients with severe kidney disease. But ...
Cached Medicine News:Health News:That anxiety may be in your gut, not in your head 2Health News:Abortions generate $95 million a year for Polish doctors as women use illegal private sector 2Health News:Biting back: Research could lead to mosquitoes being susceptible to diseases they transmit 2Health News:Biting back: Research could lead to mosquitoes being susceptible to diseases they transmit 3Health News:GPs Lack Accuracy in Spotting Skin Cancers: Study 2Health News:GPs Lack Accuracy in Spotting Skin Cancers: Study 3Health News:Contrast agent guidelines help prevent debilitating disorder 2
(Date:8/1/2014)... -- NxStage Medical, Inc. (Nasdaq: NXTM ), a leading ... H. Burbank , Chief Executive Officer, and Mathew Towse ... Annual Canaccord Genuity Growth Conference being held at the ... August 13 th at 4:30 p.m. ET.  A webcast ... .  About NxStage Medical NxStage ...
(Date:8/1/2014)... -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ... financial results for the second quarter ended June ... to see encouraging advancements in the US commercialization ... estimated total prescriptions and estimated total per week ... Arena,s President and Chief Executive Officer. "Other recent ...
(Date:7/31/2014)... Surgical Company (NASDAQ: STAA ) a leading ... systems for the eye today reported revenue for the ... a 10% increase over $18.2 million reported for the ... revenues grew 11% during the second quarter of 2014 ... of foreign currency exchange reduced sales by $0.1 million ...
Breaking Medicine Technology:NxStage to Present at the 34th Annual Canaccord Genuity Growth Conference 2Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 2Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 3Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 4Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 5Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 6Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 7Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 8Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 9Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 10Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 11STAAR Surgical Reports 10% Second Quarter Revenue Growth 2STAAR Surgical Reports 10% Second Quarter Revenue Growth 3STAAR Surgical Reports 10% Second Quarter Revenue Growth 4STAAR Surgical Reports 10% Second Quarter Revenue Growth 5STAAR Surgical Reports 10% Second Quarter Revenue Growth 6STAAR Surgical Reports 10% Second Quarter Revenue Growth 7STAAR Surgical Reports 10% Second Quarter Revenue Growth 8STAAR Surgical Reports 10% Second Quarter Revenue Growth 9STAAR Surgical Reports 10% Second Quarter Revenue Growth 10STAAR Surgical Reports 10% Second Quarter Revenue Growth 11STAAR Surgical Reports 10% Second Quarter Revenue Growth 12STAAR Surgical Reports 10% Second Quarter Revenue Growth 13STAAR Surgical Reports 10% Second Quarter Revenue Growth 14STAAR Surgical Reports 10% Second Quarter Revenue Growth 15STAAR Surgical Reports 10% Second Quarter Revenue Growth 16STAAR Surgical Reports 10% Second Quarter Revenue Growth 17STAAR Surgical Reports 10% Second Quarter Revenue Growth 18STAAR Surgical Reports 10% Second Quarter Revenue Growth 19STAAR Surgical Reports 10% Second Quarter Revenue Growth 20STAAR Surgical Reports 10% Second Quarter Revenue Growth 21STAAR Surgical Reports 10% Second Quarter Revenue Growth 22STAAR Surgical Reports 10% Second Quarter Revenue Growth 23STAAR Surgical Reports 10% Second Quarter Revenue Growth 24STAAR Surgical Reports 10% Second Quarter Revenue Growth 25
... 30 Aethlon Medical, Inc. (OTC Bulletin Board: ... devices to address infectious disease and cancer, announced today ... in the establishment of federal partnerships that advance biodefense, ... Hemopurifier®. The Aethlon Hemopurifier® is the first medical device ...
... 30 Covance Inc. (NYSE: CVD ) ... (EURONEXT: SAN and NYSE: SNY ) for ... ten years, Covance expects to provide drug development services ... billion to $2.2 billion.  Sanofi-aventis will sell their Porcheville, ...
Cached Medicine Technology:Aethlon Medical Engages Fabiani & Company to Advance U.S. Government Partnerships 2Aethlon Medical Engages Fabiani & Company to Advance U.S. Government Partnerships 3Aethlon Medical Engages Fabiani & Company to Advance U.S. Government Partnerships 4Aethlon Medical Engages Fabiani & Company to Advance U.S. Government Partnerships 5Covance and Sanofi-Aventis Sign Definitive Agreements for 10-Year Strategic R&D Alliance 2Covance and Sanofi-Aventis Sign Definitive Agreements for 10-Year Strategic R&D Alliance 3
... OCULUS Pachycam is the first compact ... keratometer. The OCULUS Pachycam has ... ocular pressure) in accordance with Shah ... IOP. The OCULUS Pachycam is ...
World's first commercially available vacuum assisted biopsy device for MRI....
... ultrasound and MRI-guided vacuum assisted breast biopsies ... the patented, FDA-cleared ATEC system for a ... method of breast biopsy. Its compassionate care ... trust YOU.,12 Gauge Handpieces: Useful for biopsy ...
... can perform stereotactic, ultrasound and MRI-guided vacuum ... your office. Use the patented, FDA-cleared ATEC ... more clinically advanced method of breast biopsy. ... the women who trust YOU.,9 Gauge Handpieces: ...
Medicine Products: